Primary Hepatobiliary Cancer Cohort of Central China

Inclusion Criteria

• •1. ≥18 years old,
• •2. life expectancy is at least 6 months.
• •3. Diagnosed as primary liver cancer or biliary malignant tumor by histopathology or confirmed by imaging as HCC (by the AASLD or guidance for the diagnosis and treatment of primary liver cancer of China (version 2022).
• •4. At least one measurable lesion (RECIST v1.1)
• •5. Subjects volunteer to participate in the study and sign informed consent.